Joel Batzofin

Peritoneal fluid plasminogen activator activity in endometriosis and pelvic adhesive disease

Plasminogen activator activity in PF was assayed by the fibrinolysis method described by Strickland and Beers. In 45 patients studied, there were no discernible differences according to whether patients had endometriosis and/or pelvic adhesive disease. No differences were detected according to when in the menstrual cycle the sample of PF was obtained. These data are in concordance with a previous report and taken together suggest that there is no difference in fibrinolytic mechanisms in PF in patients with or without endometriosis and/or pelvic adhesive disease, when compared with control subjects. If such differences exist, they may be present in the tissues, per se, but are not discernible in PF.

IVF-Surrogates of Donated Oocytes

Parenthood through surrogacy has been used throughout history as a treatment of infertility as noted in both Old and New Testaments.1 Increasing numbers of couples are utilizing surrogate parenting to establish their families.1,2 Utian and associates3 were the first to report in 1985 on a successful in vitro fertilization (IVF)-surrogacy pregnancy in a woman who gestated a genetically unrelated embryo. This form of assisted reproduction appears best described as IVF-surrogacy and this nomenclature will be used hereafter.